Investors seeking exposure to the specialty chemicals and advanced materials space often encounter two distinct names: CBT (Cabot Corporation) and NGVT (Ingevity Corporation). Though both companies produce engineered materials for industrial and automotive end markets, their strategic trajectories, financial profiles, and near-term catalysts differ markedly. Cabot is a well-established global leader in carbon black for tires and specialty chemicals, while Ingevity is reshaping its portfolio around high-margin activated carbon and pavement technologies. This comparison explores how these two stocks stack up in the current market environment, offering perspective for traders and investors evaluating relative positioning in the materials sector.
CBT (Cabot Corporation), headquartered in Boston, Massachusetts, is a global specialty chemicals and performance materials company with approximately $3.7 billion in annual revenue and roughly 4,100 employees across 39 manufacturing locations worldwide. The company operates through two primary segments: Reinforcement Materials, which supplies carbon black primarily to the tire industry, and Performance Chemicals, encompassing specialty carbons, battery materials, fumed metal oxides, and aerogel products.
In recent market activity, Cabot has navigated a demanding macroeconomic landscape with mixed results. The company generated $665 million in operating cash flow in its most recent fiscal year, supported by strong capital discipline that enabled $96 million in dividend payments and $168 million in share repurchases. However, revenue declined year-over-year as global Reinforcement Materials volumes contracted, pressured by elevated tire imports from Asia into Western markets and softer demand in the Americas and Asia Pacific regions. On a positive note, the Performance Chemicals segment showed resilience, with battery materials revenue growing approximately 20% year-over-year, driven by demand for conductive carbons used in energy storage applications. The company also announced an agreement to acquire Bridgestone's reinforcing carbons plant in Mexico, a move expected to strengthen its North American manufacturing footprint. Looking ahead, management has guided for adjusted EPS in the range of $6.00 to $7.00 for the coming fiscal year, reflecting an uncertain trade environment and ongoing competitive headwinds.
NGVT (Ingevity Corporation), headquartered in North Charleston, South Carolina, is a specialty materials company operating across three segments: Performance Materials (activated carbon for automotive emissions control), Advanced Polymer Technologies (caprolactone-based specialty polymers), and Performance Chemicals (pavement technologies and road markings). The company employs approximately 1,500 people across 24 locations globally.
Ingevity's recent performance has been defined by aggressive portfolio repositioning. The company announced the sale of the majority of its Industrial Specialties product line and its North Charleston crude tall oil refinery for $110 million, with proceeds directed toward debt reduction. Simultaneously, management revealed it is exploring strategic alternatives for the Advanced Polymer Technologies and Road Markings segments. The core of the "New Ingevity" strategy centers on two industry-leading businesses: Performance Materials, which generates EBITDA margins above 50% from automotive activated carbon, and Pavement Technologies, where the company holds a dominant position in warm-mix asphalt additives. In recent quarters, Ingevity delivered its sixth consecutive period of year-over-year adjusted EBITDA margin expansion, reaching 33.5%, while reducing net leverage from 3.5x to 2.6x. Free cash flow generation reached a five-year high, enabling share repurchases and accelerated deleveraging. For the coming year, management projects adjusted EPS of $4.80 to $5.20 on approximately $1.1 billion to $1.2 billion in net sales from continuing operations.
For traders seeking an analytical edge in evaluating stocks like CBT and NGVT, Tickeron's Trending AI Robots page offers access to a curated selection of AI-driven trading bots. Tickeron hosts hundreds of AI Trading Bots that collectively trade thousands of different tickers across equities, ETFs, forex, and cryptocurrencies, but only the top-performing strategies aligned with current market conditions earn a place in this featured section. These bots span diverse trading styles — from short-term 5-minute and 15-minute signal agents to longer-duration swing-trading and trend-following systems — and have historically posted annualized returns ranging from approximately 78% to over 290% among leading strategies. Key performance metrics such as Sharpe ratios, drawdown levels, profit factors, and trade frequency are all transparently displayed, allowing users to evaluate risk-adjusted returns. To explore which AI-powered strategies are currently trending and suitable for today's markets, visit the Trending AI Robots page.
When placed side by side, CBT and NGVT present contrasting investment profiles across several key dimensions:
Business Model and End-Market Exposure: Cabot is deeply tied to global tire production and automotive manufacturing cycles through its Reinforcement Materials segment, which accounts for the majority of revenue. Ingevity's Performance Materials segment also serves the auto industry — specifically evaporative emission control systems — but benefits from regulatory tailwinds (increasing emissions standards) and a growing hybrid vehicle mix that requires more activated carbon content per vehicle. NGVT's Pavement Technologies segment adds infrastructure-linked diversification not present in CBT's portfolio.
Balance Sheet Strength: Cabot holds a clear advantage with a net debt to EBITDA ratio of 1.2x and total liquidity of approximately $1.5 billion, providing substantial flexibility for capital returns and strategic investments. Ingevity has made impressive progress reducing leverage from 3.5x to 2.6x, but remains more levered than Cabot and is still working toward its target range of 2.0x to 2.5x.
Growth Drivers: Cabot's growth narrative centers on battery materials, where contribution margin grew 20% year-over-year, alongside the Mexico acquisition. Ingevity's growth story revolves around its warm-mix asphalt technology (Evotherm), filtration market expansion, and steadily rising activated carbon content per vehicle as global emissions standards tighten.
Risk Factors: CBT faces near-term pressure from Asian tire import competition and tariff-related demand uncertainty. NGVT carries execution risk from its ongoing portfolio restructuring, including the divestiture of non-core businesses and strategic reviews that could introduce earnings volatility. Both companies are exposed to global auto production trends, which have remained below prior peaks.
Based on observable factors such as trend consistency, margin trajectory, and strategic catalysts, Tickeron's AI analytical framework would likely tilt in favor of NGVT (Ingevity Corporation) in the current environment. The six consecutive quarters of EBITDA margin expansion signal a persistent positive trend, while the portfolio simplification toward two high-margin, technology-differentiated businesses reduces complexity and sharpens the growth narrative. The company's improving free cash flow generation and rapid deleveraging further strengthen the case for relative stability. That said, CBT (Cabot Corporation) offers a compelling value proposition through its fortress balance sheet, consistent shareholder returns, and battery materials growth potential — factors that may appeal to a different class of risk-conscious investors. In probabilistic terms, NGVT's restructuring momentum and margin leadership present a slightly more favorable risk-reward profile for trend-oriented strategies, while CBT's discounted valuation and cash flow durability may attract those prioritizing capital preservation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CBT’s FA Score shows that 2 FA rating(s) are green whileNGVT’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CBT’s TA Score shows that 4 TA indicator(s) are bullish while NGVT’s TA Score has 6 bullish TA indicator(s).
CBT (@Chemicals: Specialty) experienced а -2.36% price change this week, while NGVT (@Chemicals: Specialty) price change was -0.20% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +1.40%. For the same industry, the average monthly price growth was -1.39%, and the average quarterly price growth was +3.90%.
CBT is expected to report earnings on Aug 03, 2026.
NGVT is expected to report earnings on Nov 04, 2026.
The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
| CBT | NGVT | CBT / NGVT | |
| Capitalization | 4.54B | 2.51B | 181% |
| EBITDA | 752M | 207M | 363% |
| Gain YTD | 34.317 | 23.538 | 146% |
| P/E Ratio | 16.61 | 102.97 | 16% |
| Revenue | 3.58B | 1.16B | 308% |
| Total Cash | 252M | 97.4M | 259% |
| Total Debt | 1.3B | 1.24B | 105% |
CBT | NGVT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 58 | 7 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 62 | 100 | |
SMR RATING 1..100 | 48 | 18 | |
PRICE GROWTH RATING 1..100 | 43 | 44 | |
P/E GROWTH RATING 1..100 | 12 | 15 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CBT's Valuation (30) in the Industrial Specialties industry is significantly better than the same rating for NGVT (98) in the Chemicals Major Diversified industry. This means that CBT’s stock grew significantly faster than NGVT’s over the last 12 months.
CBT's Profit vs Risk Rating (62) in the Industrial Specialties industry is somewhat better than the same rating for NGVT (100) in the Chemicals Major Diversified industry. This means that CBT’s stock grew somewhat faster than NGVT’s over the last 12 months.
NGVT's SMR Rating (18) in the Chemicals Major Diversified industry is in the same range as CBT (48) in the Industrial Specialties industry. This means that NGVT’s stock grew similarly to CBT’s over the last 12 months.
CBT's Price Growth Rating (43) in the Industrial Specialties industry is in the same range as NGVT (44) in the Chemicals Major Diversified industry. This means that CBT’s stock grew similarly to NGVT’s over the last 12 months.
CBT's P/E Growth Rating (12) in the Industrial Specialties industry is in the same range as NGVT (15) in the Chemicals Major Diversified industry. This means that CBT’s stock grew similarly to NGVT’s over the last 12 months.
| CBT | NGVT | |
|---|---|---|
| RSI ODDS (%) | N/A | 5 days ago 73% |
| Stochastic ODDS (%) | 4 days ago 70% | 4 days ago 64% |
| Momentum ODDS (%) | 4 days ago 68% | 4 days ago 67% |
| MACD ODDS (%) | 4 days ago 60% | 4 days ago 84% |
| TrendWeek ODDS (%) | 4 days ago 65% | 4 days ago 72% |
| TrendMonth ODDS (%) | 4 days ago 65% | 4 days ago 70% |
| Advances ODDS (%) | 6 days ago 68% | 7 days ago 74% |
| Declines ODDS (%) | 4 days ago 66% | 5 days ago 70% |
| BollingerBands ODDS (%) | 4 days ago 65% | 4 days ago 76% |
| Aroon ODDS (%) | 4 days ago 65% | 4 days ago 67% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DAMD | 1.72 | 0.05 | +2.99% |
| Defiance Daily Target 2X Short AMD ETF | |||
| TSLG | 3.62 | 0.05 | +1.40% |
| Leverage Shares 2X Long TSLA Daily ETF | |||
| NCZ | 15.46 | 0.20 | +1.31% |
| Virtus Convertible & Income Fund II | |||
| EWP | 61.48 | 0.04 | +0.07% |
| iShares MSCI Spain ETF | |||
| GABF | 45.31 | 0.03 | +0.06% |
| Gabelli Financial Services Opp ETF | |||